Friday, 14 October 2016

Burnaby Pharmacy - Ajit Johal

Burnaby Pharmacy - Ajit Johalhttp://theexperts.ca/blog/2016/10/15/burnaby-pharmacy-ajit-johal/ ‎

pharmaceutical-products-expert



Immunosenescence: The Impact of Influenza on Adults 65 years of age and older



As people age, they become more suscep­tible to influenza-related complications due to “immunosenescence”, a natural and pro­gressive weakening of the immune system over time.



In Canada, influenza generally occurs every year in the late fall and winter months. It is estimated that between 10-20% of the popu­lation becomes infected with influenza each year (1), with the following groups having the HIGHEST RATES of INFECTION;




  • Children aged 5-9

  • Adults over the age of 65

  • Those with underlying medical conditions



Influenza remains a serious public health concern, with up to 8,000 influenza-related deaths reported annually, and 90% of these deaths occurring in individuals over 65 years of age (2).



Why are Adults over the age of 65 at higher risk?



Immunosenescene is a heightened suscep­tibility to influenza-related complications in older adults due to the natural and progres­sive weakening of the immune system over time. As a result of immunosenescence, lower immune responses can result in;




  • Increased incidence and severity of infec­tious diseases

  • A reduction in the strength of persistence of antibody responses to vaccines (3)



Is the flu vaccine effective?



A field vaccine effectiveness (FVE) study of 10 influenza epidemic seasons for those over 65 years of age and under found a consistently lower response for people aged over 65 than for younger adults (4). As a result of immunosenescence seniors are less responsive to standard dose influenza vaccine.



In order to ensure an optimal immune re­sponse a new vaccine has been developed to account for immunosenescence, and provide better protection for seniors. This Vaccine is Fluzone High Dose.



Fluzone High Dose



Fluzone high dose contains 4 times the an­tigen of a standard dose influenza vaccine (60 ug vs 15 ug per dose). The vaccine has demonstrated through a large randomized study (over 30,000 patients) to be more efficacious (24.2%) than standard dosing vaccine (5).



What does this mean for you?



If you are 65 or older, consider getting the Fluzone high dose vaccine for this upcom­ing flu season, instead of the standard dose vaccine distributed by public health. Consider the benefits of the vaccine, but keep in mind that it is not a publically funded vaccine (cost is 65$ per dose vs public vac­cine = free for those who qualify). Wilson Pharmacy will be providing both vaccines, and the pharmacy team is available to an­swer all of your flu/health related questions to ensure that you stay healthy this season.



2185 Wilson Avenue, Suite 3 Port Coquitlam, BC • www.wilsonpharmacy.ca



References:



1.CCDR. An advisory Committee Statememt (ACS). National Advisory Committee on Immunization (NACI). Statement on Seasonal Influenza Vaccine for 2013-2014



2.Stats Can. The 10 Leading Causes of Death, 2011. http://www.statcan.gc.ca/pub/82-625-x/2014001/article/11896-eng.htm. Accessed Jun 23rd 2016



3.Public Health Agency of Canada (PHAC). Canadian Immunization Guide. General Guidelines. 2013



4.Legrand J, et al. Real-time monitoring of the influenza vaccine field effectiveness. Vaccine. 2006. 24;6605-6611



5.DiazGranados, C,. Dunning, A., Kimmel, M et al. Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults. N Engl J Med 2014; 371:635-45

No comments:

Post a Comment